In conclusion, our results demonstrate that activating EV secretion reduces intracellular CYFIP2 levels, further supporting that the accumulation of CYFIP2 protein in FXS neurons is due to the compromised EV release. The gene discussed is CYFIP2; the disease is fragile X syndrome.